麻豆传媒

Feature Channels: Weight Loss

Filters close
Go to Advanced Search

Not for public release

This news release is embargoed until 4-Apr-2025 10:00 AM EDT Released to reporters: 31-Mar-2025 7:30 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Apr-2025 10:00 AM EDT The 麻豆传媒 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 31-Mar-2025 5:00 PM EDT Released to reporters: 25-Mar-2025 7:35 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-Mar-2025 5:00 PM EDT The 麻豆传媒 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 31-Mar-2025 5:00 PM EDT Released to reporters: 25-Mar-2025 7:30 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-Mar-2025 5:00 PM EDT The 麻豆传媒 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 31-Mar-2025 10:50 AM EDT
Under Embargo: Landmark Research Recommends Gastric Bypass for People with Severe Obesity Undergoing Surgery
University of Bristol

Gastric bypass is the most clinically and cost effective form of interventional surgery for people living with severe obesity, reveals landmark research. The new University of Bristol-led trial, funded by the National Institute for Health and Care Research (NIHR), is published today [31 March] in the Lancet Diabetes & Endocrinology journal.

Released: 26-Mar-2025 11:00 AM EDT
Most Older Adults Say Medicare and Other Insurance Should Cover Obesity Drugs, and Many Show Interest in Using Them
Michigan Medicine - University of Michigan

A large majority of older Americans feel that health insurance 鈥 including Medicare 鈥 should cover anti-obesity medications, according to a new study. And more than half of older adults who meet criteria for obesity say they鈥檙e interested in trying one of these drugs to manage their weight.

Released: 26-Mar-2025 9:40 AM EDT
Weight-Loss Drug Use Has Risen Sharply Among Children and Adults With Type 1 Diabetes
Johns Hopkins Bloomberg School of Public Health

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs鈥 safety and effectiveness in this patient population, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

Released: 25-Mar-2025 9:00 AM EDT
Program announced for NUTRITION 2025 to be held May 31鈥揓une 3
American Society for Nutrition (ASN)

Don鈥檛 miss NUTRITION 2025, the annual flagship meeting of the American Society for Nutrition, to be held May 31鈥揓une 3 in Orlando. Get an up-close view of the latest nutrition science findings, opportunities and debates, with more than 1,500 original research studies being presented at this year鈥檚 event.

Released: 23-Mar-2025 5:00 AM EDT
Improving GLP-1 Drug Delivery by 鈥楶ainting鈥 It on Antibodies
American Chemical Society (ACS)

Researchers have 鈥減ainted鈥 GLP-1 receptor agonists onto antibodies through a reaction that happens inside the body. In animal models, a single dose worked better and lasts longer than currently administered dosages. They will present their results at ACS Spring 2025.

   
Released: 23-Mar-2025 5:00 AM EDT
Mejora en la administraci贸n del GLP-1 al 芦pintarlos禄 en los anticuerpos
American Chemical Society (ACS)

Los investigadores han 芦pintado禄 los agonistas del receptor del GLP-1 en anticuerpos a trav茅s de una reacci贸n que se produce dentro del organismo. En modelos animales, una sola dosis actu贸 mejor y dur贸 m谩s que las dosis administradas en la actualidad. Presentar谩n sus resultados en el encuentro de primavera de 2025 de la ACS.

   
麻豆传媒: The Medical Minute: Don鈥檛 Snooze on Sleep Apnea
Released: 19-Mar-2025 6:45 PM EDT
The Medical Minute: Don鈥檛 Snooze on Sleep Apnea
Penn State Health

Does your partner keep leaving for the guest room because of your snoring? You could have sleep apnea. A Penn State Health sleep medicine specialist explains the serious health effects of this often-overlooked condition 鈹 and the treatments that can help you get a restful night鈥檚 sleep.

麻豆传媒: Rutgers Launches Center to Tackle Barriers to Weight Loss and Other Causes of Disease
Released: 18-Mar-2025 6:30 PM EDT
Rutgers Launches Center to Tackle Barriers to Weight Loss and Other Causes of Disease
Rutgers Robert Wood Johnson Medical School

Rutgers Launches Center to Tackle Barriers to Weight Loss and Other Causes of Disease

Released: 18-Mar-2025 5:40 PM EDT
Anti-obesity medication boosts weight loss when behavioral therapy falls short
Perelman School of Medicine at the University of Pennsylvania

Adding an anti-obesity medication just one month after behavioral therapy begins鈥攔ather than waiting the currently recommended six months鈥攃an more than double weight loss for patients who struggle initially with lifestyle changes alone, according to new research published in Nature Medicine from a team at the Perelman School of Medicine at the University of Pennsylvania.

麻豆传媒: Beyond Eggs: Protein Sources That Strike the Right Balance
Released: 10-Mar-2025 8:05 PM EDT
Beyond Eggs: Protein Sources That Strike the Right Balance
UT Southwestern Medical Center

High-protein diets and protein-enriched foods seem to be everywhere we turn. It鈥檚 a nutrition trend with a refreshingly positive vibe. Unlike carbohydrates and fats, protein is the only one of the three macronutrients that doesn鈥檛 get vilified 鈥 instead of cutting back, we鈥檙e encouraged to boost our intake!

Released: 4-Mar-2025 11:00 AM EST
Researchers Discover a Cause of Leptin Resistance鈥攁nd How to Reverse It
Rockefeller University

Most obese patients grow resistant to satiety signals from the hormone leptin. A new study shows that leptin sensitivity can be restored in mice, leading to weight loss.

Released: 25-Feb-2025 9:00 AM EST
Press Passes Available for NUTRITION 2025 to Be Held May 31鈥揓une 3
American Society for Nutrition (ASN)

Complimentary press passes are now available for NUTRITION 2025, the annual flagship meeting of the American Society for Nutrition, May 31鈥揓une 3 in Orlando.

麻豆传媒: Online Weight Loss Program Is Effective Way to Reach Rural Populations, Study Shows
Released: 13-Feb-2025 10:00 PM EST
Online Weight Loss Program Is Effective Way to Reach Rural Populations, Study Shows
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

A research team at the University of Illinois Urbana-Champaign developed an online weight management program that provides personalized assistance from a registered dietitian. In a new study, they collaborated with Illinois Extension to test the program鈥檚 efficacy among residents of rural Illinois.

麻豆传媒: Popular Diabetes/Weight-Loss Drugs Show Additional Benefit
Released: 10-Feb-2025 6:10 PM EST
Popular Diabetes/Weight-Loss Drugs Show Additional Benefit
UT Southwestern Medical Center

A well-known class of drugs used to manage Type 2 diabetes and control weight could offer hope for patients who also struggle with related chronic kidney disease (CKD), researchers at UT Southwestern Medical Center found.



close
2.30792